FDA Delays Final Approval of Novavax COVID Vaccine

FRIDAY, April 4, 2025-- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the agency now says it needs more information before moving forward.The...